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Abstract
Background: Increasing physical activity, improving diet, and performing brain training exercises are associated with reduced
cognitive decline in older adults.
Objective: In this paper, we describe a feasibility trial of the Active Brains intervention, a web-based digital intervention
developed to support older adults to make these 3 healthy behavior changes associated with improved cognitive health. The Active
Brains trial is a randomized feasibility trial that will test how accessible, acceptable, and feasible the Active Brains intervention
is and the effectiveness of the study procedures that we intend to use in the larger, main trial.
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Methods: In the randomized controlled trial (RCT), we use a parallel design. We will be conducting the intervention with 2
populations recruited through GP practices (family practices) in England from 2018 to 2019: older adults with signs of cognitive
decline and older adults without any cognitive decline. Trial participants were randomly allocated to 1 of 3 study groups: usual
care, the Active Brains intervention, or the Active Brains website plus brief support from a trained coach (over the phone or by
email). The main outcomes are performance on cognitive tasks, quality of life (using EuroQol-5D 5 level), Instrumental Activities
of Daily Living, and diagnoses of dementia. Secondary outcomes (including depression, enablement, and health care costs) and
process measures (including qualitative interviews with participants and supporters) will also be collected. The trial has been
approved by the National Health Service Research Ethics Committee (reference 17/SC/0463).
Results: Results will be published in peer-reviewed journals, presented at conferences, and shared at public engagement events.
Data collection was completed in May 2020, and the results will be reported in 2021.
Conclusions: The findings of this study will help us to identify and make important changes to the website, the support received,
or the study procedures before we progress to our main randomized phase III trial.
Trial Registration: International Standard Randomized Controlled Trial Number 23758980;
http://www.isrctn.com/ISRCTN23758980
International Registered Report Identifier (IRRID): DERR1-10.2196/18929
(JMIR Res Protoc 2020;9(9):e18929) doi: 10.2196/18929
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Introduction
Background and Rationale
The prevalence of dementia is estimated to be between 5% and
7% among those aged 65 years and above [1,2]. Although the
rates have fallen slightly in the United Kingdom over the past
20 years [2], the absolute number of cases is likely to increase
owing to longer life spans [3]. Over the next 30 years, 10-15
million cases are predicted in Europe [3], and 132 million in
the world by 2050 [4], with approximately 43% of prevalent
cases needing high-level care (equivalent to nursing home care)
[3]. It has been estimated that if interventions could delay both
disease onset and progression by one year, there would be nearly
9.2 million fewer cases of the disease worldwide by 2050,
almost all attributable to a reduction in persons needing a high
level of care [3].
Cognitive impairment in the absence of dementia is common,
but prevalence estimates vary considerably depending on the
definition [5]. Mild cognitive impairment (MCI) is the most
commonly used definition, conventionally defined as a
deterioration in at least one nonmemory cognitive domain in
addition to memory impairment, without severe functional
impairment or loss of independence in Instrumental Activities
of Daily Living [3,6]. The incidence of MCI is high in those
aged above 65 years [7-9], ranging from 51 to 76.8 per 1000
person-years. There is not enough evidence yet that screening
for MCI is either effective or cost-effective [10], but a systematic
review of cohort studies suggests that between 5% and 10% of
MCI cases progress into dementia annually [11]. However,
defining cognitive impairment solely in terms of MCI misses
a large group of individuals who are at a similar risk of
developing dementia [12-14]. An alternative way of
characterizing cognitive impairment is age-associated cognitive
decline (AACD). AACD is described as 1 SD below normal
cognitive functioning in any cognitive domain, with some
investigators considering an additional criterion (self-report of
a gradual decline in memory present for at least 6 months) [5].
The estimated prevalence of AACD depends on the number of
cognitive domains assessed and whether additional criteria are
used, which may explain the variable prevalence estimates—in
one population-based study, up to 20% of those aged above 60
years had AACD using the simple criteria described by Ritchie
et al [14] and as low as 1.4% in the UK Cognitive Functioning
and Ageing Studies, where detailed criteria were used [5].
Progression to dementia is common no matter which definition
is used, with rates almost comparable with that of MCI: 9% per
annum in a population-based study (additional criterion not
used) [14] and 10% in Cognitive Functioning and Ageing
Studies (additional criterion used) [12,13]. Importantly, there
is currently no diagnostic or treatment pathway for people with
AACD. Given the scale of the problem, there are clearly
insufficient resources on offer to help prevent cognitive decline
or dementia in those with cognitive impairment or to prevent
the development of cognitive impairment.
There is mounting evidence that healthy behaviors (particularly
physical activity) and cognitive exercises improve cognitive
functioning and activities of daily living, and a recent trial from
other settings has demonstrated the potential effectiveness of
combining healthy behavior and cognitive interventions [15].
Healthy Behaviors: Physical Activity and Healthy
Eating
Several large cohort studies and systematic reviews indicate
that leisure time physical activity—even at moderate intensity
levels—is protective, as is greater fish and fruit and vegetable
consumption, with increased risks shown for obesity and high
saturated fat intake [16-23]. The Caerphilly cohort is
representative of the UK population and measures protective
factors (not smoking, BMI levels, fruit and vegetable intake,
physical activity, and moderate alcohol intake [22]), and after
30 years, it demonstrated markedly reduced risks of cognitive
impairment (odds ratio [OR] for having 4 to 5 protective risk
factors=0.36 and dementia OR=0.36). A trial of the
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Mediterranean diet for over four years demonstrated beneficial
effects on cognitive decline among those with no cognitive
deficits at baseline: changes in cognitive z-scores were 0.04
(95% CI −0.09 to 0.18) for the Mediterranean diet plus olive
oil, 0.09 (−0.05 to 0.23 vs controls) for the Mediterranean diet
plus nuts, and −0.17 (−0.32 to −0.01) for the control diet [24].
Interventions to increase physical activity are protective in the
shorter term [25] with effects even at 6 months to a year on both
cognitive decline, gray matter volume, and atrophy [26-28].
The population attributable risk (PAR) has been estimated for
diabetes, hypertension, obesity, physical inactivity, depression,
smoking, and low educational attainment, with the highest PAR
found for physical inactivity (PAR 21.8%, 95% CI 6.1-37.7)
[29].
Cognitive Exercises
A systematic review of cognitive exercise trials [30] documented
a strong effect size in cognitive performance (weighted mean
difference=1.07; 95% CI 0.32 to 1.83; n=3194) with effects
maintained after 2 years. A more recent systematic review of
cognitive and memory training among those with MCI
documented substantial heterogeneity of interventions [31] but
a promising effect of cognitive exercises (effect sizes ranging
from 0.10 to 1.21). The large Advanced Cognitive Training for
Independent and Vital Elderly study investigated the effect of
training in several cognitive domains (memory, reasoning, and
processing speed) [32]; the change in reasoning (effect
size=0.26) was particularly important, resulting in significantly
less functional decline in activities of daily living, which was
maintained over 5 years. Booster training produced additional
improvement in reasoning performance (effect size=0.28) [33].
Feasibility of Online Delivery
Although there is evidence that suggests healthy behavior
changes can be protective against cognitive decline, behavioral
interventions are complex and resource intensive, if delivered
by purely face-to-face methods. In contrast, the internet is now
used extensively and successfully by older people for
self-management of health [33,34]. Although many individuals
may benefit from using an intervention independently, the
additional impact of behavioral facilitation may be important
in helping initiate and maintain behavior change [35,36], and
the effectiveness and cost-effectiveness of a more intensive
intervention may vary with the risk of developing dementia.
Internet Use Among Older Adults
Recent UK government statistics demonstrate that the proportion
of older adults using the internet is rapidly increasing. Among
those aged 55 to 64 years, 88.3% reported recent (in the past 3
months) internet use. Although this proportion declines across
age groups, this age group has demonstrated the fastest growth.
Over the past 7 years, the proportion of adults aged 75 years
and above reporting recent internet use has nearly doubled from
20% in 2011 to 47% in 2019 [37].
The research team has extensive experience of ensuring
intervention engagement and accessibility to encompass a range
of user preferences [38] and has experience of successfully
supporting older patients, for example, exercises for dizziness
[39], rehabilitation for stroke [40], and fall prevention [41]. The
team can also draw upon existing experiences of developing
suitable interventions to ensure engagement and accessibility
for people of all ages and computer abilities, including those
with lower health literacy [38,42].
Internet-Delivered Interventions Among a Cognitively
Impaired Population
A large trial (n=2912) led by one of the research team’s
coinvestigators (CB) [43] used a web-based cognitive training
package in our target populations (Reasoning and
problem-solving Cognitive Training [ReaCT] package) with
improvements after 6 months in instrumental activities of daily
living, reasoning, and verbal learning (standardized effect sizes
of 0.15, 0.42, and 0.18, respectively). There were very similar
effect sizes among those with cognitive impairment (AACD).
This suggests that a web-based package is likely to be feasible
and effective among those with cognitive decline. Although
some people in our target population are currently not internet
users, this proportion is rapidly declining [44]; therefore, the
findings of this study will be relevant to the large majority of
the older adult population in the future.
Intervening With Noncognitively Impaired Older Adults
Intervening with noncognitively impaired older adults may also
prevent dementia. Although an intervention for noncognitively
impaired older adults may be expected to have a smaller effect,
data from the large ReaCT trial [43] suggest that this is not
necessarily the case. Furthermore, the noncognitively impaired
older adults are a substantially larger proportion of the
population, so an intervention to target this group provides
potential for helping many more of the older adult population.
This population is also very concerned about developing
dementia: 80% of those aged 50 years or above in a survey
undertaken by Saga (n=9049) said they feared dementia, which
was equivalent to the fear of cancer, and 84% feared dementia
in their partners, which was more than they feared cancer in
their partners [45]. Fear of dementia, the need to improve
dementia knowledge, and having adequate support for
behavioral change rather than simply being told what to do are
likely to be major motivators toward changing health behaviors
in an older adult general population group [46]. Thus, it is
plausible that a well-designed and engaging behavioral
intervention to help prevent cognitive decline and dementia will
be both well-received and effective among an older adult general
population sample and will be strongly supported by their
partners.
Objectives
The primary aim of this study (the Active Brains
study—feasibility trial ISRCTN 23758980) is to assess the
feasibility and acceptability of our trial procedures and of a
web-based digital intervention (Active Brains), which helps
support people in making healthy changes (physical activity,
brain training, and diet) to maintain cognitive function and
prevent cognitive decline.
Primary Research Objective
The primary outcome was to investigate the feasibility of
collecting clinical outcomes and notes review data. This is built
around our stop or go criteria for the proposed full RCT: the
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project will progress to a full RCT if 80% of the clinical
outcome and notes review data from randomized participants
are available for analysis. If the figures are 70%-80%, we will
discuss our plans for appropriate mechanisms to increase the
response rate with the trial steering committee. If less than 70%
of the data are available, in negotiation with the funder, we will
consider not proceeding to the main trial unless there is a clear
and plausible plan to increase response rates or reduce missing
data. The feasibility and resource requirements for recruitment
will also affect the likelihood of progression to the main trial.
Secondary Research Objectives
The evaluation of feasibility and acceptability in terms of (1)
suitability of recruitment screening methods; (2) acceptability
of all trial procedures (eg, recruitment, randomization, study
materials, follow-up); (3) recruitment and attrition rates; (4)
acceptability of the digital intervention (uptake, usage, attrition,
and qualitative process evaluation); (5) appropriateness of the
human support module (uptake, adherence, number of sessions,
and qualitative process evaluation); (6) suitability of all outcome
measures; and (7) Health Economics analysis—the key resources
to be collected—to inform the choice of quality of life
instruments to be used in the full trial.
We will also explore the analysis of the characteristics of
outcomes for power calculations to confirm the target sample
size for the trial and preliminary estimates of change in relevant
behaviors (based on automatically recorded intervention usage,
eg, goals set and reviewed, scores on brain training games).
Study Design
The randomized controlled study will use a parallel design.
Participants will be divided into cognitively impaired and
noncognitively impaired subgroups based on existing cognitive
impairment (each subgroup is treated as a separate trial for
randomization and reporting). A total of 180 participants from
each group will be randomly allocated to 1 of 3 study groups
(totaling 360 participants):
1. Usual care (60 participants from each group).
2. Access to the Active Brains intervention (60 participants
from each group).
3. Access to the Active Brains intervention with flexible
human support from a central support facilitator (60
participants from each group).
It is anticipated that the noncognitively impaired group will
recruit more quickly than the cognitive impairment group, due
to the low prevalence of MCI and AACD within the age group.
Participants exceeding the allocated group size of 180 will not
be randomized but will be offered to access the intervention (no
support) as part of a cohort group.
Methods
Study Setting
Primary care recruitment will involve practice staff inviting
patients from searches of UK practice lists based in England
(GPs [General Practitioners] will screen practice lists to avoid
inviting those who have an existing diagnosis of dementia and
who are terminally ill or seriously mentally ill) between October
2018 and January 2019. Participants will also be recruited
opportunistically during consultations with practitioners.
Invitation letters, participant information sheets, reply slips (for
those not interested to inform us why), and a getting started
card with instructions on how to log on to the website to start
the study will be sent from GP practices. Participants can also
contact the research team directly if they have any questions.
Following informed consent, GP practices will be asked to
provide demographic data (gender, age, and postcode to help
us establish the level of deprivation) for all participants who
are invited to the study. We will compare the demographics of
those invited but who do not participate in the study with
recruited participants to examine any differences between these
2 groups. This will help the assessment of the likely
generalizability of our findings.
Eligibility Criteria
Figure 1 outlines the participant identification and screening
procedures. Participants recruited through primary care will be
screened to include only participants aged between 60 and 85
years and to exclude persons with a diagnosis of dementia,
terminal illness, serious mental illness, or persons within the
same household.
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Figure 1. Randomized controlled trial and pilot study procedure flowchart. AACD: age-associated cognitive decline; MCI: mild cognitive impairment.
When participants first access the Active Brains study website,
they will be asked to sign up with a username, password, and
their unique ID code (provided on their study invitation letter).
They are then presented with the information sheet and
web-based consent form to complete. If they consent, they then
answer a series of screening questions to ensure that they fit the
study inclusion criteria (shown in Textbox 1). Age, dementia
diagnosis, and the same household questions will be repeated
in the web-based screening. Additionally, web-based screening
will include willingness and ability to access the internet, the
Godin Leisure Time Exercise Questionnaire (this questionnaire
[47] will be used to screen highly physically active participants
as it is a short and simple measure, collecting only sufficient
data for screening participants and tailoring intervention content.
The International Physical Activity Questionnaire [48] will be
used to assess physical activity as an outcome measure as it has
higher granularity and assesses sedentary behavior, which is
targeted in the intervention), the Instrumental Activities of Daily
Living Questionnaire (IADL) [49], and 4 cognitive tasks (short
computer games that evaluate cognitive skills). If eligible,
participants will be asked to complete baseline measures (Table
1).
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Textbox 1. Inclusion and exclusion criteria for the Active Brains feasibility trial.
Step 1: General practitioner screening
Inclusion criteria
• Between 60 and 85 years of age
Exclusion criteria
• Diagnosis of dementia
• Terminal Illness
• Serious mental illness
Step 2: Web-based screening
Inclusion criteria
• Able and willing to access the internet
• Cognitive impairment group: ≥1 SD below the norm on the Baddeley Reasoning Test [44]
• No cognitive impairment group: <1 SD below the norm (or above norm) on the Baddeley Reasoning Test [44]
Exclusion criteria
• High levels of leisure time physical activity (score ≥30 on Godin Leisure Time Exercise Questionnaire [47] (moderate or vigorous physical
activity only)
• Another member of the household already participating in the study
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Table 1. Outcome measures and times presented to each group for the Active Brains feasibility trial.
GroupTimeMeasure
Nonrandomized cohort
study participants (re-
ceiving the Active
Brains intervention)
Active Brains interven-
tion and support from
central facilitator
Active Brains inter-
vention
Usual
care
12-month
follow-up
Baseline
✓✓✓✓—b✓aSociodemographic data
✓✓✓✓✓✓Clinical and behavioral data
—✓✓✓✓—Clinical measures (from notes review)
✓✓✓✓✓✓Cognitive Performance Tasks [50-53]
✓✓✓✓✓✓Instrumental Activities of Daily Living
[49]
✓✓✓✓✓—The Patient Enablement Scale [48]
✓✓✓✓✓✓International Physical Activity Ques-
tionnaire [54] plus strength and balance
itemsc
✓✓✓✓✓✓EQ-5D-5Ld [55]
—✓✓✓✓—EQ-5D-5L-proxy version 2 (for contact
person completion if required) [55]
✓✓✓✓✓✓ICEpop CAPability measure [56]
✓✓✓✓✓✓Short-form Health Survey [57]
✓✓✓✓✓—Dementia diagnosis (from notes re-
view)
—✓✓✓✓—Mortality
—✓✓✓✓—Health economic analysis of cost-effec-
tiveness (from notes review)
✓✓✓✓✓✓Food Frequency Questionnaire [58]
✓✓✓—✓—Problematic Experiences of Therapy
Scale [59]
✓✓✓✓✓✓Brief Geriatric Depression Scale
[60,61]
✓✓✓✓✓✓Self-efficacy for exercise [62]
✓✓✓✓—✓Medical Outcome social support Sur-
vey [63,64]
✓✓✓✓✓—Social Support for Exercise [65]
✓✓✓✓✓✓Locus of Causation in Exercise [66]
✓✓✓—✓—Technology Acceptance Model Per-
ceived Ease of Use scale [67-69]
—✓✓—✓—Informant Questionnaire on Cognitive
Decline in the Elderly–short form (if
participants do not complete full mea-
sures) [70]
Objective patient data
✓✓✓———Use of the Active Brains interven-
tion
Objective supporter data
—✓✓———Supporters’ use of Active Brains
intervention (throughout the study)
—✓✓———Emails sent to participants
throughout the study
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GroupTimeMeasure
Nonrandomized cohort
study participants (re-
ceiving the Active
Brains intervention)
Active Brains interven-
tion and support from
central facilitator
Active Brains inter-
vention
Usual
care
12-month
follow-up
Baseline
Qualitative data
—✓✓✓——Interviews with patients about
their experiences of the study
and/or intervention
—✓✓✓——Interviews with Central Support
Facilitators about their experiences
of the study and intervention
a✓: indicates yes.
b—: indicates no.
c“During the last 7 days, on how many days did you do activities or exercises to improve your strength and balance? Examples would be exercises such
as standing on one leg, doing repeated sit to stands in a chair, lifting weights or heavy objects at home or at a gym or using resistance bands. Please
only include time where you have purposefully decided to do these exercises for improving strength and balance.” Response requested: Number of days
and number of hours or minutes on an average day.
dEQ-5D-5L: EuroQol-5D 5 level.
Subgroups of cognitively impaired participants will be identified
by combinations of impairment in the Baddeley reasoning
cognitive task, IADL, and memory cognitive task. Key
subgroups are MCI, which will be defined as 1.5 SD below the
norm in a nonmemory cognitive domain plus memory
impairment [5,12,13], and AACD will be defined as 1 SD below
the norm for the Baddeley Reasoning Test [50] and IADL.
Assignment of Interventions
Simple randomization will be used to assign participants to
intervention arms using the study software’s computer-generated
random numbers. Randomization occurs online after a
participant completes baseline measures, ensuring blind
randomization. They will have an equal chance of being in each
of the 3 groups. Once randomized, participants will be informed
of their group allocation (they will also be emailed this
information). If participants are in one of the treatment arms,
they will be taken directly to the Active Brains intervention.
These participants can then use the Active Brains intervention
as much as they would like to over the course of the study. The
central facilitator will be notified by email when a participant
is randomized to the support arm of the trial, so that they know
to expect to provide support to the participant in the coming
weeks. Research staff will not be blinded to the participant
group but the statistician and health economists conducting the
analyses will be.
Patient and Public Involvement
At the outset, the project recruited 2 older adult patient and
public involvement (PPI) representatives to inform the
development of the intervention and trial. They contributed to
the development of the protocol and early intervention drafts.
When intervention development began, it was determined that
further PPI input would be essential to make the intervention
and study materials engaging and easy to use. Three older adult
representatives were recruited. Their input was invaluable in
providing direction and feedback on the content and structure
of the intervention (eg, the name, logo, content, order of pages)
as well as the consent processes, interview topic guides,
screening, and study measures (eg, feedback on unsuitable
phrasing, resolving questionnaire burden).
During and after the trial, the PPI representatives will inform
the discussion and interpretation of the trial outcomes and
process evaluations and provide a patient perspective on
resolving problems with recruitment, retention, participant
support, and follow-up.
Active Brains Intervention
The Active Brains intervention was developed to provide
interactive tailored support to older adults in initiating and
maintaining evidence-based behaviors that support cognitive
and physical health using appropriate behavior change
techniques. All intervention content has been iteratively
developed with extensive input from the target user group to
ensure that it is highly accessible and engaging. The Active
Brains study website (containing the consent material and the
study measures) is accessible to all participants, with only the
intervention arm participants having access to the Active Brains
intervention content. For the first 7 months, the intervention
groups will have access to the Active Brains “Starter Section,”
which provides support for users to initiate changes to their
lifestyle in line with the intervention’s recommendations.
Within the first section of the Active Brains intervention, 3
modules will become available to users, released sequentially.
Within these modules, users will have access to information
addressing common concerns, instructions about recommended
activities, guided goal setting and reviewing, personalized
motivational feedback about their progress, and motivational
reminder emails. The modules are as follows:
• Active Lives: a physical activity module that provides
guidance on general physical activity, strength and balance
exercises, and decreasing sedentary behavior.
• Brain Training: access to online
Brain Training
games.
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• Eat for Health: guidance on healthy eating and increasing
intake of foods beneficial for cognitive health.
After 6 months, users will be given access to the Active Brain
“Booster Section,” providing further advice on habit formation
and additional resources.
Textbox 2 summarizes the Active Brains intervention using the
Template for Intervention Description and Replication (TIDieR)
checklist [71]. For more details on the development of the Active
Brains intervention, see the study by Essery et al (unpublished
data, 2020).
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Textbox 2. Description of the Active Brains intervention using the Template for Intervention Description and Replication checklist.
1. Brief name
• Active Brains Study
2. Why
• An aging population places strains on health services: particularly with the increase in dementia. Several lifestyle changes have been found to
help protect against cognitive decline. The aim of this study is to develop and test a digital behavior change intervention to help older adults
increase their physical activity, improve their diet and practice cognitive 'Brain Training' activities to reduce cognitive decline.
3. What material?
• Assessment: All participants will complete web-based questionnaires and complete the four cognitive assessment games at 0 and 12 months
• Intervention Group: Participants in this group receive access to the Active Brains digital intervention.
• Intervention with support group: Participants in this group will receive the Active Brains digital intervention and additionally will be offered up
to eight 10 minute support phone calls with a trained supporter.
• Control Group: Participants in this group will receive usual care from their GP and brief web-based advice about getting more active, improving
diet and staying mentally active.
• The Active Brains Digital Intervention contains 4 sections described below.
• Month 0: Active Brains Starter Section. Access to 'Active Lives', including 'Strength and Balance', 'Taking Breaks from Sitting' and 'Getting
Active'. These modules contain: Information addressing common concerns; Provision to order a step counter and guidance on using it; User
stories modeling overcoming barriers; Instructions about obtaining social support; Suggestions for environment restructuring; Instructions about
recommended activities (including Strength and Balance videos); Facilities to set, plan and review goals about their chosen activities; Tailored
motivational feedback about their progress; Reminder emails to motivate them to continue with their activities and to revisit intervention content
as appropriate.
• Month 1: Access to Brain Training. This module provides: Brief information about the rationale and evidence base for Brain Training tasks and
how they are intended to work; User stories modeling overcoming barriers; Access to six web-based brain training games (via the existing
PROTECT website) which they are encouraged to play between three and five times per week; facilities to set, plan and review goals about their
chosen activities; tailored motivational feedback about their progress; reminder emails to motivate them to continue with their activities; Six
additional games are made available to users during months 1-6
• Month 2: Access to Eat for Health. This module contains: Information on the benefits of healthy eating for cognitive and physical health;
Information and techniques to allow them to make healthy changes to their existing eating behaviors (eg, increasing fruit and vegetable consumption,
cutting down on processed foods); Facilities to set, plan and review goals about their chosen activities; User stories modeling overcoming barriers;
Tailored motivational feedback about their progress; Reminder emails to motivate them to continue with their activities; Recipes
• Month 6: Transition to Active Brains Booster Section. This module contains: Tailored summary of their progress and engagement with the Starter
Section content; Links to additional resources for additional support and to extend their progress with the behavioral changes made.
• The content was developed to support self-efficacy and autonomy. It used simple and accessible language, using persuasive rather than directive
phrasing (ie, “you can” rather than “do”), and promoting guided choice rather than direction (eg, offering a range of ideas for goals).
4. What procedure
• Screening and randomization: Participants will complete web-based screening to ensure eligibility. Participants will then complete cognitive
tasks and the Instrumental activities of daily living (IADL) questionnaire to determine work stream (with or without cognitive impairment). If
the assigned work stream is full (capped at n=180), participants will be given access to Active Brains (no support) as part of a cohort study.
Participants in each work stream will be randomized to one of the three groups. They will be informed of their group allocation on the website
immediately.
• Intervention Group: Participants will receive full access to the Active Brains intervention. They will receive regular emails to remind them to
access the intervention. They will be sent reminder emails when follow-up measures are available to complete.
• Intervention with Support Group: Participants will receive full access to the Active Brains intervention. Participants in this group will additionally
be sent emails from an assigned supporter. They will be invited to book phone call appointments to support them with their use of the intervention.
• Control Group: Participants will receive basic information online about getting more active, improving diet and staying mentally active. They
will be sent reminder emails when follow-up measures are available to complete.
5. Who provided
• Assessment: Participants will be invited to take part using a letter from their GP practice. They will access the screening and measures online.
• Intervention Group: Participants will use the intervention online.
• Intervention with Support group: Participants will additionally be provided with support from trained supported from the university of Southampton.
These are members of the research team who have completed brief web-based training in the CARE approach. The CARE (Congratulate, Ask,
Reassure, Encourage) approach is intended provide support to patients based on Self-Determination Theory. Supporters will also offer technical
support.
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6. How
• Intervention delivered entirely online.
• Follow-up procedures may include telephone and post.
7. Where
Intervention delivered entirely online, intended to be used in the participant's home.
8. When and how much
• Intervention Group: The intervention is divided into a 'Starter Section', lasting 6 months and a 'Booster' section provided at 6 months. The starter
section unlocks 'Active Lives' at month 0, 'Brain Training' at month 1 and 'Eat for Health' at month 2. Participants will be encouraged to set goals
and plans for each section and return to review the goals after one week. After 'Brain Training' unlocks, participants will be encouraged to set a
goal to play the games 3-5 times a week until month 6, and then play for 3-5 times a week for a month every 3 months. Initially 6 games will be
available with new games unlocking every month until 12 games are available. Participants will be guided to form healthy habits so that after 6
months they will be less reliant on the intervention. For participants with a BMI>30, a weight loss tool 'POWER' will be offered at month 6.
• Intervention with support group: In addition to the intervention, these participants will be offered three support phone calls at weeks 2, 6 and 10.
They may request up to 8 phone calls in total.
9. Tailoring
• The intervention will tailor physical activity recommendations to self-rated Strength and Balance and current physical activity. Participants may
then choose any or all of the three physical activity modules.
• Strength and balance exercises are tailored to self-rated strength and balance.
• The weight loss tool will only be offered to participants with a BMI>30.
• Goal review feedback will be tailored to prior performance (the past two review ratings for that module).
10. Modification
• The intervention will not be modified during the trial.
11. How well
• The intervention was created using the Person-Based Approach (PBA). Experts in digital behavior change oversaw the development. End users
were consulted at all points of development and the intervention was iteratively refined to overcome anticipated barriers. The intervention was
thoroughly tested by the research team to ensure that there were minimal problems with the software.
Participants will be encouraged to set and review goals every
week when using Active Brains. When they unlock “Brain
Training,” they will be encouraged to play the games 3 to 5
times per week for the first 6 months. The intervention will be
available to the participants for a year. However, the Active
Brains intervention aims to help participants establish healthy
habits (eg, regular walking) so that participants are not
dependent on the intervention in the long term—we anticipate
that participants will not need to use the website every week
for 6 months to gain benefits from the intervention. The level
of engagement that is effective in improving outcomes will be
investigated in the main trial.
Central Facilitator Support
Patients in the group receiving support from a central facilitator
(in addition to the website) will be offered a brief (10 min)
telephone support call 2 weeks after they begin the study. In
this support call, they will discuss the cognitive or lifestyle
changes that they are planning to try. Patients will be offered 2
more support contacts by phone (up to 10 min) or email to
support them in making behavioral changes.
Central facilitators will be people trained in the congratulate,
ask, reassure, and encourage (CARE) approach to provide
support to patients, which is based on Self-Determination Theory
[72] and designed to promote autonomous motivation for
making behavioral changes. This approach has been successful
in previous trials [73].
Usual Care
The comparison group will receive usual care from their GP
practice, in addition to brief web-based advice about becoming
more physically active, improving the diet, and staying mentally
active.
Outcome Measures
Table 1 presents a list of the measures and when they will be
presented to participants. Participants will receive follow-up
reminders by email, post, and telephone and by contacting a
nominated contact person (optional). If no contact is successful,
the contact person will be asked to help put the research team
in touch with the participant or to complete 3 short
questionnaires about the participant (EQ-5D-5L proxy version
2 [55], IADL [49], and Informant Questionnaire on Cognitive
Decline in the Elderly [70]).
Participant Timeline
Participants will register, be randomized, and complete baseline
measures. Participants in the intervention arm will then be given
access to the intervention, which they can use for one year.
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Participants in the support arms will be invited to have a support
call at weeks 2, 6, and 10. A sample of participants will be
invited to participate in a qualitative process interview at 6
months. All participants will be invited to complete outcome
measures at 12 months.
Sample Size
This is a feasibility trial, so it was not powered to measure
patient outcomes. A sample size of 180 for each of the 2
subgroups was chosen for several reasons. As Active Brains is
a digital intervention with multiple possible pathways through
it, a sufficiently large group would be required to observe
different patterns of usage. Fully web-based interventions are
easy to recruit and manage larger numbers of participants,
making this possible. The proposed fully powered trial would
need to recruit over 20,000 patients, so implementation issues
and trial processes (eg, managing multiple supporters) needed
to be tested at scale. A total of 360 participants would provide
robust evidence for the feasibility of the trial.
Data Collection, Management, and Analysis
Outcome measures will be collected by using the software at
registration and at one year. It will be held securely in a database
accessible only by the data controller and members of the study
team. Each participant will be assigned a unique study ID when
they register with the website. Anonymous outcome data will
be held in a separate write-only database to the personally
identifiable data to ensure blinding and guard against
modification.
Personally identifiable data will be held in accordance with the
General Data Protection Regulation [74]. It will only be
accessible to members of the study team throughout the study
to monitor usage and provide support. The data will be analyzed
by a statistician who has had no access to these data.
Statistical Analysis
The primary analysis will determine whether the feasibility trial
has met the stop or go criteria and will therefore describe the
completeness of the data in relation to the number of participants
recruited.
Data for the secondary analyses will be explored descriptively
and graphically for the other key feasibility outcomes, including
intervention uptake, adherence, attrition, retention, and the
number of participants recruited per practice. We will estimate
the variability of proposed outcome measures and discuss any
implications for the sample size for the full trial.
All participant data will be analyzed, including those who have
withdrawn, unless the participant specifically requests for their
data to be removed. All participants will be analyzed as
randomized. The pattern and frequency of missing data will be
explored descriptively in the feasibility context to determine
whether there are whole instruments or items on instruments
that participants opted not to complete and to inform the stop
or go decision for the full trial.
The same outcomes will be assessed in a cohort study to explore
whether it is feasible to recruit additional participants and collect
data to inform future implementation in this way.
For the feasibility study, we will provide only descriptive
estimates (ie, we will not be performing an inferential analysis
to establish whether there are significant differences between
groups).
Health Economic Analysis
At this feasibility stage, we aim to collect resource usage
information associated with the intervention and explore and
identify the likely changes in practice due to the intervention
through questionnaires, case note review, and qualitative
interviews. We plan to develop and refine the methods for
collecting such information and to inform the choice of which
instrument will be used to measure quality of life for the later
planned, fully powered trial.
The study will explore both the National Health Service (NHS)
and social service perspectives. All itemized resource usage
will be costed using published information (eg, the Personal
Social Services Research unit [75], the BNF [76]). Quality of
life will be measured using EQ-5D [55], ICECAP [56], and
SF-12 [57] at baseline and 12 months. We will apply the UK
tariff to translate the questionnaire scores to utility scores. We
aim to test the sensitivity and feasibility of these instruments in
the study population, hence informing the choice of the
instrument in the full trial.
The economic analyses of costs and quality of life will be mainly
descriptive (with mean and standard deviation). We will
correlate all utility scores with the planned primary outcome
[50] to see the magnitude of sensitivities. The focus will be on
the direction of correlation, spread, and confidence intervals.
Such information will allow us to investigate the most relevant
resource use of information to be collected and inform choice
of the quality of life instrument to be used in the definitive trial.
Qualitative Process Analysis
There will be 2 qualitative process studies, one with participants
and one with central support facilitators. Interviews in both
these studies may be carried out at any time between 2 and 12
months after participants begin the study. Both of these studies
will allow assessment of the acceptability and feasibility of the
intervention and highlight any modifications to the intervention
or study procedures that might be required before embarking
on the later planned, fully powered trial.
Qualitative Process Study With Participants
We will interview 12 to 18 participants from each of the
intervention arms, employing purposive sampling to ensure a
diverse range of participants in terms of demographic and
clinical profiles as well as website usage. Participants will be
invited to participate by the research team and asked if they
would be willing to take part in a telephone interview. They
will complete a separate consent form (online) before taking
part in an interview. During the interview, open-ended questions
will be used to explore participants’ perceptions of the study,
the website (if in one of the intervention groups), and the support
they received from the central facilitator (if in the support
group). Those in the control group will be asked about the brief
advice they were given at baseline.
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Qualitative Process Study With Central Support
Facilitators
The second substudy will use face-to-face or telephone
interviews to explore central support facilitators’ views of the
study procedures, the website, the training they were provided,
and the support they provided to patients (including perceptions
of the CARE approach).
Analysis
Data from both qualitative process studies will be analyzed
using inductive thematic analysis with interrater agreement
reached between team members. The findings will be discussed
and interpretations agreed between the coinvestigators (including
PPI representatives).
Monitoring Adverse Events
Serious adverse events (SAEs) will be reported by both
participants, practice staff, and possibly by the central support
facilitators who will have contact with participants during the
study. It is not anticipated that SAEs will be related to this
research. SAEs are defined as any untoward medical occurrence
or effect that at any dose results in death, is life threatening,
requires hospitalization or prolongation of existing
hospitalization (excluding hospitalization for pre-existing
conditions or planned procedures), results in persistent or
significant disability or incapacity, is a congenital anomaly or
birth defect, or results in other important medical events. Any
SAE occurring to a research participant will be reported to the
ethics committee where, based on the initial judgement made
by the chief investigator or an agreed deputy, the event was
related to the administration of any of the research procedures
and was an unexpected occurrence. Nonserious adverse events
will not be collected.
GP practices and the central support facilitation staff will inform
the research team and/or the Clinical Trials Unit of any SAEs
within 24 hours of them being aware of the event occurring.
GP practices and central support facilitation staff will be
provided with a standard operating procedure and a form for
SAE reporting. Patients may also report SAEs. Reports of SAEs
will be provided to the ethics committee within 15 days of the
chief investigator becoming aware of the event. In addition to
the chief investigator making the initial judgement about the
SAE, all SAEs will also be sent to the trial steering committee
for adjudication.
Ethics
Informed Consent
Participants will be fully informed of the risks and benefits of
the study and their right to withdraw at any time for any reason.
Consent will be collected digitally before data collection.
Ethical Approvals
Ethical approval for the Active Brains study was obtained from
the NHS Research Ethics Committee (IRAS ID 239448, REC
number 17/SC/0463). Research and development approvals
were obtained from relevant clinical research networks.
Results
The results of this trial will be published in peer-reviewed
journals and presented at conferences. Findings will be conveyed
to the public through press releases and public engagement
activities (eg, science fairs). Findings will be sent to all GP
practices and participants who request them. Social media (eg,
Twitter) will also be used to share publications and
dissemination activities to the wider academic community and
the general public. If found to be feasible, Active Brains will
proceed to a full RCT.
Recruitment for this study was conducted from October 2018
to January 2019. All data were collected and the trial website
was closed by May 2020. The analysis will be conducted in
2020, and results will be published in 2021. The prospective
main trial will begin in late 2020.
Discussion
The Active Brains feasibility trial has several strengths. First,
the design of the intervention can be easily implemented at
scale—this will be useful for the planned larger RCT and, if
found to be effective, future dissemination to the public. Second,
the development of the intervention used a person-based
approach (combining theory, evidence, and primary qualitative
research)—this has improved its chance of being acceptable
and effective. Active Brains is the first web-based digital
intervention to test this combination of evidence-based
behavioral components for reducing cognitive decline (targeted
physical activity, healthy eating, and brain training). This study
will provide evidence for the feasibility of conducting a trial of
an intervention similar to Active Brains and help us to improve
upon the delivery of a larger trial. Limitations of the study are
that this trial does not look at the long-term impact of healthy
behavior change on cognitive health. This will be examined in
a subsequent RCT.
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